Stock listing
A2QA48 Stock Price, News, Filings & Events — Actinium Pharmaceuticals, Inc. (delaware)
Selected listing: A2QA48 · LS · EUR · DE
This page tracks Actinium Pharmaceuticals, Inc. (delaware)'s A2QA48:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2QA48:LS. A2QA48:LS is the stock-level entry point for investors researching Actinium Pharmaceuticals, Inc. (delaware), while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2QA48:LS
- Asset type
- Stock
- Market cap
- $44.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Actinium Pharmaceuticals, Inc. (delaware) A2QA48:LS stock context
This page tracks Actinium Pharmaceuticals, Inc. (delaware)'s A2QA48:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2QA48:LS. A2QA48:LS is the stock-level entry point for investors researching Actinium Pharmaceuticals, Inc. (delaware), while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Actinium Pharmaceuticals, Inc. (delaware)
Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update
August 14, 2026
Actinium Presents New ATNM-400 Data in KRAS and EGFR Mutant Models at SNMMI 2026 Supporting a Mutation-Agnostic Opportunity In Non-Small ...
June 3, 2026
Actinium Pharmaceuticals Oral Presentation at SNMMI 2026 Highlights ATNM-400 Overcoming Resistance to All Three Approved Androgen Recepto...
June 3, 2026
Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development
June 1, 2026
Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs
May 29, 2026
Research Actinium Pharmaceuticals, Inc. (delaware)
Actinium Pharmaceuticals, Inc. (delaware) investor report
Review AI stock analysis and investor report context for A2QA48:LS.
Actinium Pharmaceuticals, Inc. (delaware) company profile
View the public company page for Actinium Pharmaceuticals, Inc. (delaware) on 6ix.
Actinium Pharmaceuticals, Inc. (delaware) news
Read company news and market updates connected to Actinium Pharmaceuticals, Inc. (delaware).
Actinium Pharmaceuticals, Inc. (delaware) investor events
Find investor webinars, events, and replay context for Actinium Pharmaceuticals, Inc. (delaware).
Alternate listings
ATNM:AMEX
US · USD
Alternate listing for Actinium Pharmaceuticals, Inc. (delaware); the primary context on this page is A2QA48:LS.
7AY1:GETTEX
DE · EUR
Alternate listing for Actinium Pharmaceuticals, Inc. (delaware); the primary context on this page is A2QA48:LS.
A2QA48:LSX
DE · EUR
Alternate listing for Actinium Pharmaceuticals, Inc. (delaware); the primary context on this page is A2QA48:LS.
7AY1:TRADEGATE
DE · EUR
Alternate listing for Actinium Pharmaceuticals, Inc. (delaware); the primary context on this page is A2QA48:LS.
ATNM:BOATS
US · USD
Alternate listing for Actinium Pharmaceuticals, Inc. (delaware); the primary context on this page is A2QA48:LS.
7AY1:SWB
DE · EUR
Alternate listing for Actinium Pharmaceuticals, Inc. (delaware); the primary context on this page is A2QA48:LS.
7AY1:DUS
DE · EUR
Alternate listing for Actinium Pharmaceuticals, Inc. (delaware); the primary context on this page is A2QA48:LS.
7AY1:FWB
DE · EUR
Alternate listing for Actinium Pharmaceuticals, Inc. (delaware); the primary context on this page is A2QA48:LS.